Outcomes of sleeve gastrectomy and Roux-en-Y gastric bypass in patients with liver disease and body mass index ≥ 40: analysis using the 2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database
Outcomes of sleeve gastrectomy and Roux-en-Y gastric bypass in patients with liver disease and body mass index ≥ 40: analysis using the 2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database. // Surgery for Obesity and Related Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S155072892600746X?dgcid=rss_sd_all
Outcomes of sleeve gastrectomy and Roux-en-Y gastric bypass in patients with liver disease and body mass index ≥ 40: analysis using the 2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database. Surgery for Obesity and Related Diseases. https://www.sciencedirect.com/science/article/pii/S155072892600746X?dgcid=rss_sd_all
“Outcomes of sleeve gastrectomy and Roux-en-Y gastric bypass in patients with liver disease and body mass index ≥ 40: analysis using the 2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database.” Surgery for Obesity and Related Diseases.
@article{article66857,
title = {Outcomes of sleeve gastrectomy and Roux-en-Y gastric bypass in patients with liver disease and body mass index ≥ 40: analysis using the 2023 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database},
journal = {Surgery for Obesity and Related Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S155072892600746X?dgcid=rss_sd_all}
}